A carregar...
Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis()
BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare, progressive and frequently lethal cystic lung disease that almost exclusively affects women and has no proven therapies. An improved understanding of the pathogenesis has identified promising molecular targets for clinical trials. Although barrie...
Na minha lista:
| Publicado no: | Respir Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4407662/ https://ncbi.nlm.nih.gov/pubmed/19962873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmed.2009.09.023 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|